|
|
 |
|
Viewing report
|
|
|
|
Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
iData Research, Jan 2011, Pages: 307
This report details the responses of a comprehensive survey conducted of interventional cardiologists, interventional radiologists and cardiac surgeons on product preferences, placement techniques and trends in the use of drug eluting and bare metal stents, bifurcated stents, bioabsorbable stents, stent grafts, vulnerable plaque diagnosis and treatment and endovascular imaging technologies. The Global Physician Survey on Stents, Stent-Grafts and Endovascular Imaging includes:
- The United States
- Europe
- Asia-Pacific
- Latin America
- Middle East
- Africa
This report covers:
- Number and Type of Stents Placed
- Type of Endovascular Imaging Used
- Bifurcated Stents and Their Use
- Most Important Benefit When Using Bifurcated Stents
- Preferred Bifurcated Stent Alternative
- Bioabsorbable Stents and Their Use
- Most Important Benefit When Using Bioabsorbable Stents
- Most Important Bioabsorable Stent Drawback
- Most Important Drug-Eluting Stent Concern
- Most Effective Drug-Eluting Stent Drug for Combating Restenosis
- Stent-Graft Brand Preference
- Most Important Construction Feature for Stent-Grafts
- Most Important Design Feature for Next Generation Stent-Grafts
- The Use of Thoracic Aortic Aneurysm (TAA) Stent-Grafts
- Concerns about the Use of TAA Stent-Grafts
Keywords:
Stents, Endovascular Imaging, Bifurcated Stents, Bioabsorbable Stents, Drug-Eluting Stent, Stent-Graft, Thoracic Aortic Aneurysm (TAA), Abbott Laboratories, Boston Scientific, Cordis, Cook Medical, ev3, Endologix, Jomed Medtronic, W. L. Gore
Also available
Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011 (Executive Summary)
|
|
|
|
